ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Immunosuppression"

  • 2022 American Transplant Congress

    Frequency of Cervical Cancer Screening in Solid Organ Transplant Recipients

    C. Papastamelos1, K. Dokus2, M. Laryea3

    1Internal Medicine, University of Rochester Medical Center, Rochester, NY, 2Transplant Division, University of Rochester Medical Center, Rochester, NY, 3Gastroenterology, University of Rochester Medical Center, Rochester, NY

    *Purpose: Human papillomavirus-related anogenital malignancies disproportionately affect solid organ transplant recipients (SOTR) compared to the general population. Proposed cervical Pap testing intervals for SOTR differ…
  • 2022 American Transplant Congress

    Long-Term Rejection Free Renal Allograft Survival with Fc-Modified Anti-cd154 Antibody Monotherapy in Nonhuman Primates

    G. Lassiter, T. Hirose, A. D’Attilio, T. Kawai

    MGH Center for Transplantation Sciences, Boston, MA

    *Purpose: Belatacept is currently the only FDA approved costimulatory blockade (CB) used as an alternative to calcineurin inhibitors in kidney transplantation. However, it has been…
  • 2022 American Transplant Congress

    Impact Of Antifungal Prophylaxis Discontinuation On Immunosuppression In Lung Transplant Recipients

    R. Huntsman, K. Neuhaus

    Pharmacy, Cleveland Clinic, Cleveland, OH

    *Purpose: The purpose of this study is to characterize the impact of antifungal discontinuation on immunosuppressant levels and incidence of acute rejection and fungal infections…
  • 2022 American Transplant Congress

    Associations of Immunosuppression Regimen with Fracture Risk After Kidney Transplant in High-Risk Populations: Identifying Targets for Risk-Reduction

    K. Lentine1, S. Kupacchi2, W. Cheungpasitporn3, R. Li4, Y. Caliskan4, M. Schnitzler4, M. McAdams-DeMarco5, J. Ahn5, S. Bae6, G. Hess7, D. Segev5, D. Axelrod2

    1Saint Louis University Center for Abdominal Transplantation, St. Louis, MO, 2U Iowa, Iowa City, IA, 3Mayo Clinic, Rochester, MN, 4Saint Louis University, Saint Louis, MO, 5Johns Hopkins, Baltimore, MD, 6Johns Hopkins, Baltimore, MO, 7Drexel, Philadelphia, MO

    *Purpose: Disorders of bone and mineral metabolism frequently develop with advanced kidney disease, may be exacerbated by immunosuppression (ISx) after kidney transplant (KTx), and may…
  • 2022 American Transplant Congress

    Suppressive Effect of De Novo Everolimus on Primary Cytomegalovirus Infection in Kidney Transplant Recipient

    S. Harada1, H. Sasaki2, Y. Takada2, D. Takamoto2, H. Harada2, T. Hirano2, H. Tanaka1

    1Urology, Sapporo City General Hospital, Sapporo, Japan, 2Kidney Transplant Surgery, Sapporo City General Hospital, Sapporo, Japan

    *Purpose: It has been reported that everolimus (EVR) administration reduces the incidence of cytomegalovirus (CMV) infection, but clinical outcome in CMV-seronegative recipients with EVR-based regimen…
  • 2022 American Transplant Congress

    Outcomes in Lung Transplant Recipients Switched from Tacrolimus to Cyclosporine Due to Hyperammonemia Early Post-Transplantation

    S. Goyal, J. Lyons, P. Stracener, B. Bemiss

    Loyola University Medical Center, Chicago, IL

    *Purpose: Assess the impact of switching from tacrolimus to cyclosporine due to hyperammonemia on outcomes at 1-year post-lung transplant.*Methods: A retrospective review of lung transplant…
  • 2022 American Transplant Congress

    Validation of the iBox Surrogate End Point in CNI Free, Belatacept Treated Patients (BENEFIT & BENEFIT-EXT)

    G. Divard1, O. Aubert1, M. Raynaud1, F. Vincenti2, L. Rostaing3, A. Durbach4, C. Legendre1, R. Vadanici5, A. Loupy1, -. BENEFIT & BENEFIT-EXT Investigators6

    1Paris Transplant Group, INSERM, Paris, France, 2UCSF, San Francisco, CA, 3Grenoble, Grenoble, France, 4APHP, Paris, France, 5BMS, Rueil Malmaison, France, 6BMS, New York, NY

    *Purpose: The iBox is a prognostication system for long-term kidney allograft survival, developed with mostly patients under a CNI based immunosuppression. Patients treated with a…
  • 2022 American Transplant Congress

    A Novel IL-2 Mutein Selectively Expands Regulatory T Cells and Prolongs Skin Graft Survival

    O. Efe1, T. J. Borges1, R. B. Gassen1, L. Morena1, A. Al Jurdi1, I. T. Lape1, G. J. Bobcock2, J. C. Madsen1, L. V. Riella1

    1Center for Transplantation Sciences, Massachusetts General Hospital, Charlestown, MA, 2Visterra, Inc., Waltham, MA

    *Purpose: Promoting immune regulation through expansion of regulatory T cell (Treg) may allow immunosuppression minimization and improve long-term graft outcomes. Low-dose IL-2 is known to…
  • 2022 American Transplant Congress

    Pre-Transplant Vaccine Induced SARS-CoV-2 Antibodies Decrease Following Induction Therapy for Kidney Transplantation

    N. Barros1, A. C. Ermel1, A. Sharfuddin2, W. Goggins3, J. Fridell2

    1Indiana University, Indianapolis, IN, 2Indiana University School of Medicine, Indianapolis, IN, 3Indiana University Hospital, Indianapolis, IN

    *Purpose: Kidney transplant recipients (KT) and wait-listed individuals exhibit an impaired response to vaccinations. There is currently no data on the impact of induction immunosuppression…
  • 2022 American Transplant Congress

    The Role Of Gut Microbiome In Optimum Dose Selection Of Tacrolimus For Kidney Transplant Recipients

    M. Nayebpour1, N. Koizumi1, J. Melancon2

    1George Mason University, Arlington, VA, 2George Washington University Hospital, Washington, DC

    *Purpose: This study aims to validate and apply a personalized optimal dose selection model for Tacrolimus (Tac) for kidney transplant recipients at the George Washington…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 138
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences